Myocarditis: Differences in Clinical Expression between Patients with ST-Segment Elevation in Electrocardiogram vs.
Grytė Ramantauskaitė1, Kingsley A Okeke2, Vaida Mizarienė1
1Department of Cardiology, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.
ST-segment elevation (STE) in myocarditis cases indicates more severe myocardial damage, evidenced by higher C-reactive protein (CRP) and lower left ventricular ejection fraction (LVEF). Despite this, myocarditis generally shows a favorable prognosis with treatment.
Area of Science:
- Cardiology
- Internal Medicine
- Biomarker Research
Background:
- Myocarditis can present with electrocardiogram (ECG) patterns mimicking ST-segment elevation myocardial infarction (STEMI) or non-STEMI.
- The clinical significance of ST-segment elevation (STE) in myocarditis, particularly regarding myocardial damage and severity, remains unclear.
Purpose of the Study:
- To investigate the association between ST-segment elevation (STE) patterns on ECG and myocardial damage in patients with myocarditis.
- To compare clinical, laboratory, and instrumental findings between myocarditis patients with and without STE patterns.
Main Methods:
- Retrospective study of 38 hospitalized myocarditis patients.
- Patients classified into two groups: ST-segment elevation (STE) (n=25) and non-STE (n=13).
- Analysis of epidemiological, laboratory (CRP, Troponin I), and echocardiographic (LVEF, LV strain) data.
Main Results:
- The STE group exhibited significantly higher C-reactive protein (CRP) levels (103.40 vs. 43.54 mg/L).
- The non-STE group showed a higher left ventricular ejection fraction (LVEF) (56.58% vs. 49.71%).
- Lower LVEF correlated with higher Troponin I (TnI) and CRP levels; lower LV strain correlated with higher TnI.
Conclusions:
- ST-segment elevation (STE) in myocarditis is associated with elevated CRP and reduced LVEF, suggesting more significant myocardial injury.
- Higher TnI and CRP levels correlate with worse left ventricular function.
- Myocarditis demonstrates a favorable prognosis based on 6-month echocardiographic follow-up.
More Related Videos
09:16Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
Published on: February 28, 2018
09:23Confirmation of Myocardial Ischemia and Reperfusion Injury in Mice Using Surface Pad Electrocardiography
Published on: November 24, 2016
Related Concept Videos
Myocarditis II: Clinical features and Diagnostic Tests
Acute Coronary Syndrome II: Pathophysiology and clinical manifestations
Myocarditis I: Introduction
Myocarditis III: Medical Management
Endocarditis II: Clinical features and Diagnostic Tests
Pericarditis II: Clinical features and Diagnostic Tests
